GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (BOM:532300) » Definitions » Short Percentage of Float

Wockhardt (BOM:532300) Short Percentage of Float


View and export this data going back to 2000. Start your Free Trial

What is Wockhardt Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Wockhardt's Short Percentage of Float

For the Drug Manufacturers - Specialty & Generic subindustry, Wockhardt's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wockhardt's Short Percentage of Float Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wockhardt's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Wockhardt's Short Percentage of Float falls into.


Wockhardt (BOM:532300) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wockhardt Ltd (BOM:532300) » Definitions » Short Percentage of Float
Comparable Companies
BOM:506690 BOM:524735 BOM:532612 BOM:530549 BOM:543748 BOM:509079 BOM:512529 BOM:524164 BOM:524372 NSE:RPGLIFE ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
WOCKPHARMA:India
Address
Wockhardt Towers, Bandra-Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Website
http://www.wockhardt.com
Wockhardt Ltd is a major drug manufacturing company with a focus on pharmaceutical and biotechnology products. The company conducts research in the fields of pharmaceuticals and biotechnology while also operating its chain of Super Specialty Hospitals. The vast majority of the company's revenue is generated in Europe. The company also operates in China, Japan, and Russia. The company's strategy includes the use of acquisitions, strategic partnerships, and contract manufacturing.

Wockhardt (BOM:532300) Headlines

No Headlines